Gapping down
In reaction to earnings/guidance:
- SEDG -18.5%, PACB -10.9%, ESPR -8.6%, NPTN -7.2%, OSPN -6.7%, BRKR -5.7%, FBM -5.6%, PYPL -5.5%, ICHR -5.5%, KMT -5.1%, EVER -4.6%, SRC -4.4%, MOS -4%, RCM -4%, NTR -3.8%, FRPT -3.5%, LEG -2.5%, JCI -2.4%, RMBS -2.3%, STE -1.7%, ETRN -1.7%, O -1.5%, MDLZ -0.9%
Other news:
- AUPH -8.1% (Phase 2/3 data for dry eye syndrome did not meet primary endpoint)
- DRRX -5.6% (names new Chief Medical Officer)
- FELE -1.8% (acquires Waterite)
- EDU -1.5% (prices global offering of 8,510,000 new common shares)
- BAND -0.8% (stock offering)
- BMRN -0.8% (receives acceptance from FDA for its NDA for Vosoritide; PDUFA Action Date is Aug 20)
Analyst comments:
- GHL -4.7% (downgraded to Underperform from Mkt Perform at Keefe Bruyette)
- MOS -4% (downgraded to Sector Perform from Sector Outperform at Scotiabank)